Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
20.75
↑ 46% above average
Average (9y)
14.18
Historical baseline
Range
High:68.78
Low:1.74
CAGR
+9.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 20.75 | +32.9% |
| 2023 | 15.62 | +171.9% |
| 2022 | 5.74 | +229.7% |
| 2021 | 1.74 | -77.9% |
| 2020 | 7.88 | +164.7% |
| 2019 | 2.98 | -12.1% |
| 2018 | 3.38 | -36.9% |
| 2017 | 5.36 | -92.2% |
| 2016 | 68.78 | +619.5% |
| 2015 | 9.56 | - |